ViewRay Inc VRAYQ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VRAYQ is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–1.21
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $25,309.48
- Volume/Avg
- 1,085 / 13,148
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
ViewRay Inc is a radiation therapy and imaging technology company. It designs, manufactures, and markets radiation therapy systems that provide real-time imaging during radiation treatment. Its product portfolio encompasses The MRIdian linac system, The MRIdian system, the Monte Carlo treatment planning system, etc. The company holds the license for its combination of MRI and radiation therapy technologies. Geographically, it derives a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 295
- Website
- https://www.viewray.com
Comparables
Valuation
|
Metric
|
VRAYQ
|
SIBN
|
TCMD
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 26.22 |
Price/Book Value | — | 3.66 | 1.74 |
Price/Sales | — | 4.22 | 1.21 |
Price/Cash Flow | — | — | 15.97 |
Price/Earnings
VRAYQ
SIBN
TCMD
Financial Strength
|
Metric
|
VRAYQ
|
SIBN
|
TCMD
|
|---|---|---|---|
Quick Ratio | 0.77 | 8.01 | 2.88 |
Current Ratio | 1.16 | 9.01 | 3.54 |
Interest Coverage | −16.14 | −13.52 | — |
Quick Ratio
VRAYQ
SIBN
TCMD
Profitability
|
Metric
|
VRAYQ
|
SIBN
|
TCMD
|
|---|---|---|---|
Return on Assets (Normalized) | −33.74% | −8.97% | 10.70% |
Return on Equity (Normalized) | −87.94% | −12.61% | 18.16% |
Return on Invested Capital (Normalized) | −48.87% | −11.78% | 12.90% |
Return on Assets
VRAYQ
SIBN
TCMD
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Lxhyrrfr | Vfgkx | $185.4 Bil | |
SYK
| Stryker Corp | Fhpygljspg | Dtshr | $127.7 Bil | |
BSX
| Boston Scientific Corp | Tsxqyjkv | Bdsjy | $107.6 Bil | |
MDT
| Medtronic PLC | Zpwwxsst | Wswgc | $105.9 Bil | |
DXCM
| DexCom Inc | Qchngjdpk | Skfzj | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Bptbtnhxb | Cynbkk | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Vjzhzsbfr | Nbtc | $24.6 Bil | |
ALGN
| Align Technology Inc | Bfqvbqmm | Zqdvcd | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Zfsrtnqb | Bzhywq | $18.7 Bil | |
PODD
| Insulet Corp | Cnwzlzrd | Cwsns | $11.6 Bil |